Suicidal ideation and behavior in adults with major depressive disorder treated with vortioxetine: post hoc pooled analyses of randomized, placebo-controlled, short-term and open-label, long-term extension trials

Abstract

Vortioxetine is not associated with increased risk of suicidal ideation or behavior in MDD patients.